It's Monday, April 24, 2023.

I'm Albert Moller, and this is The Briefing, a daily analysis of news and events from a

Christian-world view.

The Supreme Court of the United States handed down an order on Friday, much expected,

much anticipated.

The actual substance of the order means that the abortion pill known as Mifopristone will

continue to be distributed according to current FDA procedures.

But this does not mean that the case is over.

It does not mean that the Supreme Court will not eventually have to rule directly on the

merits of this case.

It does mean that even with an expedited process, the Supreme Court has sent the issue back

to lower courts.

Let's just remind ourselves of how we got here.

First of all, a suit was filed in a Texas Federal Court, a district court alleging that

the Food and Drug Administration, in the year 2000, that's at least the year in which

the policy was handed down, approved the use of the drug Mifopristone and its prescription

by doctors as one of two major abortion pills that would lead to medical abortion in the

United States.

The case that was made by those who were bringing the case is that the FDA violated its own

procedures and thus violated the law in this sense in pushing through the authorization

for Mifopristone.

And the case drew a great deal of national attention from the beginning.

...